Compositions and methods for treating cancer with andrographolide and melatonin combination therapy
AssigneesUniversity of Maryland, Baltimore, Glycomantra Inc.
InventorsAditi Banerjee, Steven Czinn, Hafiz Ahmed, Thomas Blanchard
Life of this patent
Estimating the term…
Abstract
The present invention provides methods for treating cancer in a subject, comprising administering to the subject an effective amount of a combination of andrographolide and melatonin. The present invention further provides compositions comprising effective amounts of andrographolide and melatonin for treating cancer.
Claims22
A method of treating cancer in a subject, comprising administering to the subject an effective amount of a combination of andrographolide and melatonin, wherein the combination of andrographolide and melatonin acts synergistically to treat cancer, wherein the cancer is metastatic colorectal cancer.
A composition for treating cancer in a subject, comprising an effective amount of a combination of andrographolide and melatonin wherein the combination of andrographolide and melatonin acts synergistically to treat cancer, wherein the cancer is metastatic colorectal cancer.
Dependencies are inferred from the claim text.